Authors:
CLAESSON K
MAYER AD
SQUIFFLET JP
GRABENSEE B
EIGLER FW
BEHREND M
VANRENTERGHEM Y
VANHOOFF J
MORALES JM
JOHNSON RWG
BUCHHOLZ B
LAND W
FORSYTHE JLR
NEUMAYER HH
ERICZON BG
MUHLBACHER F
Citation: K. Claesson et al., LIPOPROTEIN PATTERNS IN RENAL-TRANSPLANT PATIENTS - A COMPARISON BETWEEN FK-506 AND CYCLOSPORINE-A PATIENTS, Transplantation proceedings, 30(4), 1998, pp. 1292-1294
Authors:
FREI UA
NEUMAYER HH
BUCHHOLZ B
NIESE D
MUELLER EA
Citation: Ua. Frei et al., RANDOMIZED, DOUBLE-BLIND, ONE-YEAR STUDY OF THE SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION COMPARED WITH CONVENTIONAL CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS, Transplantation, 65(11), 1998, pp. 1455-1460
Citation: B. Buchholz et al., BASAL HEATING IN MAIN-SEQUENCE STARS AND GIANTS - RESULTS FROM MONOCHROMATIC ACOUSTIC-WAVE MODELS, The Astrophysical journal, 494(2), 1998, pp. 700-714
Authors:
WEIGAND M
FREI E
GRAF N
WOLFROM C
BUCHHOLZ B
WIESSLER M
Citation: M. Weigand et al., CELLULAR MECHANISMS OF RESISTANCE TO METHOTREXATE IN CHILDHOOD LEUKEMIA, European journal of cancer, 33, 1997, pp. 778-778
Authors:
KORN A
FARBER L
MAIBUCHER A
BUCHHOLZ B
OFFERMANN G
Citation: A. Korn et al., LONG-TERM EXPERIENCE WITH SANDIMMUN-NEORAL - RESULTS IN DE-NOVO AND STABLE RENAL-TRANSPLANT PATIENTS AFTER 24-MONTH TREATMENT, Transplantation proceedings, 29(7), 1997, pp. 2945-2947
Authors:
ABENDROTH D
BUCHHOLZ B
LAND W
MAY G
WIESEL M
FARBER L
KORN A
MAIBUCHER A
Citation: D. Abendroth et al., COMPARISON OF EFFICACY, SAFETY, AND TOLERABILITY OF NEORAL VS SANDIMMUN IN DE-NOVO RENAL-TRANSPLANT PATIENTS OVER 24 MONTHS TREATMENT, Transplantation proceedings, 29(1-2), 1997, pp. 275-276
Authors:
MAYER AD
DMITREWSKI J
SQUIFFLET JP
BESSE T
GRABENSEE B
KLEIN B
EIGLER FW
HEEMANN U
PICHLMAYR R
BEHREND M
VANRENTERGHEM Y
DONCK J
VANHOOFF J
CHRISTIAANS M
MORALES JM
ANDRES A
JOHNSON RWG
SHORT C
BUCHHOLZ B
REHMERT N
LAND W
SCHLEIBNER S
FORSYTHE JLR
TALBOT D
NEUMAYER HH
HAUSER I
ERICZON BG
BRATTSTROM C
CLAESSON K
MUHLBACHER F
POHANKA E
Citation: Ad. Mayer et al., MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL-ALLOGRAFT REJECTION - A REPORT OF THEEUROPEAN TACROLIMUS-MULTICENTER-RENAL-STUDY-GROUP, Transplantation, 64(3), 1997, pp. 436-443
Authors:
MORALES JM
VANHOOFF J
PICHLMAYR R
VANRENTERGHEM Y
SQUIFFLET JP
BUCHHOLZ B
NEUMAYER HH
EIGLER FW
ERICZON BG
JOHNSON RWG
MAYER AD
TAYLOR R
MUHLBACHER F
GRABENSEE B
LAND W
Citation: Jm. Morales et al., RANDOMIZED TRIAL COMPARING TACROLIMUS AND CYCLOSPORINE IN THE PREVENTION OF RENAL-ALLOGRAFT REJECTION - EUROPEAN STUDY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3351-3351
Authors:
BUCHHOLZ B
FREI E
EISENBARTH J
WEIGAND M
LUDWIG R
Citation: B. Buchholz et al., TIME-COURSE OF METHOTREXATE POLYGLUTAMATE FORMATION AND DEGRADATION IN THE PRE-B-LEUKEMIA CELL-LINE NALM6 AND IN LYMPHOBLASTS FROM CHILDRENWITH LEUKEMIA, European journal of cancer, 32A(12), 1996, pp. 2101-2107
Authors:
ERDEL M
SCHUFFENHAUER S
BUCHHOLZ B
BARTHWITTE U
KOCHL S
UTERMANN B
DUBA HC
UTERMANN G
Citation: M. Erdel et al., ROUTINE SCREENING FOR MICRODELETIONS BY FISH IN 77 PATIENTS SUSPECTEDOF HAVING PRADER-WILLI OR ANGELMAN SYNDROMES USING YAC CLONE 273A2 (D15S10), Human genetics, 97(6), 1996, pp. 784-793
Authors:
HOHAGE H
BRUCKNER D
ARLT M
BUCHHOLZ B
ZIDEK W
SPIEKER C
Citation: H. Hohage et al., INFLUENCE OF CYCLOSPORINE-A AND FK506 ON 24-H BLOOD-PRESSURE MONITORING IN KIDNEY-TRANSPLANT RECIPIENTS, Clinical nephrology, 45(5), 1996, pp. 342-344
Citation: S. Moir et B. Buchholz, EMERGING PARTICIPATORY APPROACHES TO ERGONOMIC INTERVENTIONS IN THE CONSTRUCTION-INDUSTRY, American journal of industrial medicine, 29(4), 1996, pp. 425-430
Citation: B. Buchholz et A. Korn, SAFETY AND TOLERABILITY OF SANDIMMUNE-NEORAL VS SANDIMMUNE-IN-DE-NOVORENAL-TRANSPLANT PATIENTS AFTER 24 MONTHS TREATMENT, Transplantation proceedings, 28(4), 1996, pp. 2187-2188
Authors:
KEOWN P
HAYRY P
MATHEW T
MORRIS P
STILLER C
BARKER C
CARR L
LANDSBERG D
HARDIE I
RIGBY R
ISONIEMI H
GRAY D
BELITSKY P
MCDONALD A
CLARKSON A
BARRATT L
BUCHHOLZ B
WALKER R
KIRSTE G
MUIRHEAD N
TILLER D
DUGGIN G
HALLORAN P
DALOZE P
RUSSELL D
LUDWIN D
VIALTEL P
BINSWANGER U
BUCKELS JAC
TOURAINE JL
HICKEY D
REMUZZI G
LOCATELLI B
LAM FT
Citation: P. Keown et al., A BLINDED, RANDOMIZED CLINICAL-TRIAL OF MYCOPHENOLATE MOFETIL FOR THEPREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL-TRANSPLANTATION, Transplantation, 61(7), 1996, pp. 1029-1037
Authors:
HOHAGE H
BRUCKNER D
ARLT M
BUCHHOLZ B
ZIDEK W
SPIEKER C
Citation: H. Hohage et al., EFFECTS OF FK-506 AND CYCLOSPORINE-A ON 24H BLOOD-PRESSURE PROFILES IN KIDNEY-TRANSPLANT RECIPIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1091-1091
Authors:
HOHAGE H
BRUCKNER D
ARLT M
BUCHHOLZ B
SPIEKER C
Citation: H. Hohage et al., COMPARISON OF RISK-FACTORS IN FK-506 AND CYCLOSPORINE-A TREATED TRANSPLANT RECIPIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1091-1091
Authors:
MOLLER HE
GAUPP A
VESTRING T
DIETL KH
VERMATHEN P
BUCHHOLZ B
PETERS PE
Citation: He. Moller et al., KINETICS OF METABOLISM IN HUMAN KIDNEY-TRANSPLANTS MEASURED BY DYNAMIC P-31 NMR-SPECTROSCOPY, Zeitschrift fur Naturforschung. C, A journal of biosciences, 50(5-6), 1995, pp. 439-450
Citation: H. Hohage et al., 24-HOUR BLOOD-PRESSURE MONITORING OF KIDNEY-TRANSPLANT PATIENTS WITH FK506 AND CYCLOSPORINE-A IMMUNOSUPPRESSION, Kidney international, 47(3), 1995, pp. 977-977
Authors:
HOHAGE H
SPIEKER C
SUWELACK B
BUCHHOLZ B
ZIDEK W
Citation: H. Hohage et al., METABOLIC CHANGES IN KIDNEY-TRANSPLANT PATIENTS WITH FK506 IMMUNOSUPPRESSION, Kidney international, 47(3), 1995, pp. 977-977
Authors:
HOHAGE H
SPIEKER C
SUWELACK B
BUCHHOLZ B
ZIDEK W
Citation: H. Hohage et al., COMPARISON OF SERUM ELECTROLYTES AND KIDNEY-FUNCTION PARAMETERS OF KIDNEY-TRANSPLANT PATIENTS WITH FK506 AND CYCLOSPORINE-A IMMUNOSUPPRESSION, Kidney international, 47(3), 1995, pp. 977-977
Citation: T. Baumann et al., AZIRIDINES .65. ACYCLIC AND CYCLIC GAMMA-AMIDOPROPANEPHOSPHONIC ESTERS BY AMIDOETHYLATION OF HORNER REAGENTS WITH ACTIVATED AZIRIDINES, Synthesis, (1), 1995, pp. 44-46